前列地尔联合神经节苷脂治疗老年性耳聋的临床疗效
发布时间:2018-05-06 01:43
本文选题:神经节苷脂 + 前列地尔 ; 参考:《中国老年学杂志》2017年10期
【摘要】:目的研究神经节苷联合前列地尔治疗老年性耳聋的临床疗效与安全性。方法老年性耳聋患者120例随机分为实验组和对照组各60例。对照组在常规用药基础上应用前列地尔治疗,实验组在其基础上联合应用神经节苷脂。观察两组治疗效果、听力水平、眩晕与耳鸣的改善情况以及良反应发生情况。结果治疗后,实验组痊愈17例,显效18例,总有效率93.34%;对照组痊愈14例,显效15例,总有效率76.67%。治疗后两组患者的听力水平均有显著提升,尤以实验组更明显,实验组治疗前后单耳平均听阈差值为(42±5)d B,对照组为(29±3)d B。实验组眩晕治疗有效率为84.21%,耳鸣治疗有效率为91.11%;明显高于对照组(71.43%、77.27%,P0.05)。两组不良反应轻微,减少用药剂量后症状消失。结论应用神经节苷脂联合前列地尔治疗老年性耳聋疗效较好,可有效改善患者的听力水平、眩晕与耳鸣的症状,同时用药安全性较高。
[Abstract]:Objective to study the clinical efficacy and safety of ganglioside combined with alprostadil in the treatment of presbycusis. Methods 120 patients with presbycusis were randomly divided into experimental group and control group. The control group was treated with alprostadil on the basis of routine medication, and the experimental group was treated with ganglioside on its basis. The therapeutic effect, hearing level, improvement of vertigo and tinnitus and the occurrence of good reaction were observed. Results after treatment, 17 cases were cured in the experimental group, 18 cases were markedly effective, the total effective rate was 93.34%, while in the control group, 14 cases were cured, 15 cases were markedly effective, and the total effective rate was 76.67%. After treatment, the hearing level of the two groups improved significantly, especially in the experimental group. The average hearing threshold difference before and after treatment was 42 卤5 dB in the experimental group and 29 卤3 dB in the control group. The effective rate of vertigo and tinnitus in the experimental group was 84.21 and 91.11 respectively, which was significantly higher than that in the control group (71.43) and 77.27% (P0.05). The adverse reactions in both groups were mild and the symptoms disappeared after reducing the dosage. Conclusion ganglioside combined with alprostadil is effective in the treatment of presbycusis and can effectively improve the hearing level, vertigo and tinnitus symptoms.
【作者单位】: 河北医科大学第三医院老年病内科;廊坊市人民医院门诊办公室;
【基金】:河北省科学技术研究与发展支撑计划项目(No.10206126D)
【分类号】:R764.436
【相似文献】
相关期刊论文 前8条
1 崔晶莹;;前列地尔辅助治疗缺血性视神经病变的临床疗效观察[J];中国医药指南;2010年32期
2 卢伟波;李舒敏;吕以培;黄中莹;杨丕坚;;前列地尔对早期糖尿病视网膜病变患者血管内皮功能的影响[J];山东医药;2013年24期
3 姚晓岚;赵作亚;潘延成;;前列地尔联合疏血通治疗单纯型糖尿病视网膜病变的疗效观察[J];中国现代医生;2008年05期
4 胡晓东;;前列地尔治疗突发性耳聋的临床观察[J];医药论坛杂志;2014年07期
5 毛贺娟;蒋蓉;赵倩;颜光堂;程奇;王建洪;肖世强;;前列地尔治疗突发性耳聋的临床效果观察[J];中国现代药物应用;2014年13期
6 沙倩萍;唐永良;邹帆;柯昌毅;;前列地尔、银杏达莫联合高压氧治疗突发性耳聋的临床观察[J];中国药房;2014年32期
7 黄员福;薛梅;欧锦添;李建美;;前列地尔配合早期高压氧治疗突发性耳聋耳鸣的临床效果观察[J];中国当代医药;2014年21期
8 ;[J];;年期
,本文编号:1850244
本文链接:https://www.wllwen.com/yixuelunwen/wuguanyixuelunwen/1850244.html
最近更新
教材专著